• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Tuesday, July 5, 2022
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home National

Coronavirus Vaccine Approval Requests By Serum Institute of India, Pfizer and Bharat Biotech To Be Reviewed Tomorrow

by The Outlooker Web Desk
December 8, 2020
in National
0
Bharat Biotech Starts Phase III Trials For COVAXIN
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

India has logged more than 96 lakh coronavirus cases so far.

New Delhi:

An expert panel will tomorrow review the request by three pharmaceutical firms – the Serum Institute of India, Pfizer and Bharat Biotech – to approve emergency use of their coronavirus vaccines in India, sources told NDTV.

On Monday, Hyderabad-based firm Bharat Biotech became the third firm, say sources, to put a request for approval of its vaccine – Covaxin, India’s first indigenous candidate for the highly infectious virus.

American firm Pfizer was the first to submit its application last week to the the DCGI (Drugs Controller General of India), followed by Pune-based Serum Institute of India.

After review, the expert panel will share its observations with the drug regulator, as per sources. An emergency use approval of a drug can be granted after there is sufficient evidence to suggest that the medical product is safe and effective. Final approval is granted only after completion of the trials and analysis of full data.

Serum Institute of India, the world’s largest vaccine maker by number of doses produced, is developing its vaccine – Covishield – with the University of Oxford and British drugmaker AstraZeneca. Last month, AstraZeneca had said an interim analysis of clinical trials of its COVID-19 vaccine in the UK and Brazil showed that it was 70 per cent effective on average, adding it is up to 90 per cent effective.

Last week, the United Kingdom became the first country to clear the Covid-19 shot developed jointly by Pfizer and German biotechnology partner BioNTech, which has reported an efficiency of 95 per cent in the third stage of trials.

Experts have voiced concerns about logistical challenges linked to Pfizer vacine, which needs to be stored and transported at -70 degrees Celcius. However, the pharma firm has asserted it’s prepared to overcome these hurdles.

Newsbeep

Adar Poonawala’s SII was mired into controversy after a Chennai volunteer’s allegation of serious adverse effects. But the government last week said it had found no reason to stop the Oxford vaccine trials in India. The vaccine was “safe and immunogenic” and the Data and Safety Monitoring Board and the Ethics Committee had “independently cleared” the trials after examining the complaint, the Pune-based firm asserted.

Yesterday, he tweeted:  “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD. This will save countless lives, and I thank the Government of India and Sri @narendramodi ji for their invaluable support.” 

Haryana Health Minister Anil Vij, who took a single dose of Bharat Biotech’s Covaxin in the third state of trials, said on Saturday he had tested positive for coronavirus. However, the vaccine maker later clarified that Covaxin has been designed to be effective if a person takes two doses. “Covaxin clinical trials are based on a 2-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days post the 2nd dose,” the Hyderabad firm said in an official statement.

The emergency use authorisation by the DCGI will allow the vaccine to be administered to people under certain conditions – for a limited period of time or on specific groups.

India has logged 96.7 lakh Covid infections so far, the second highest in the world after the United States, and 1.4 lakh deaths linked to the disease.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Sensex, Nifty may open flat; five factors that could define stock market movement today

Sensex, Nifty may open flat; five factors that could define stock market movement today

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

HDFC, HDFC Bank share prices jump over 1% as RBI approves merger proposal; should you buy, sell, hold?
Business

HDFC, HDFC Bank share prices jump over 1% as RBI approves merger proposal; should you buy, sell, hold?

July 5, 2022
UP Man Sells Chicken On Paper With Photo Of Hindu God, Goddess; Arrested: Report
National

UP Man Sells Chicken On Paper With Photo Of Hindu God, Goddess; Arrested: Report

July 5, 2022
Dr Reddy’s Laboratories rating: Buy | Healthy financials should aid growth
Business

Dr Reddy’s Laboratories rating: Buy | Healthy financials should aid growth

July 4, 2022
3 Injured After Argument Over Pet Dog In Delhi: Police
National

Jail Inmate Dies By Suicide In UP: Cops

July 4, 2022

Connect with us

No Result
View All Result

Archives

  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • HDFC, HDFC Bank share prices jump over 1% as RBI approves merger proposal; should you buy, sell, hold?
  • UP Man Sells Chicken On Paper With Photo Of Hindu God, Goddess; Arrested: Report
  • Dr Reddy’s Laboratories rating: Buy | Healthy financials should aid growth

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.